Treatment of Periodontal Disease With Two Different Bioactive Gels for Home Oral Care
Periodontal Diseases
About this trial
This is an interventional treatment trial for Periodontal Diseases focused on measuring split-mouth, periodontal gel, scaling and root planning, periodontal disease, dental hygiene
Eligibility Criteria
Inclusion Criteria:
Presence of periodontal disease according to the recent 2017 classification (2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions):
1.1 Severity from grade I onwards (grade I: clinical attachment loss of 1-2 mm, bone loss in the cervical third greater than 15%, no elements loss for periodontitis);
1.2. Complexity from grade II onwards (grade II: maximum probing depth of 5 mm, bone loss mainly horizontally);
- Presence of bilateral periodontal probes, both to the right and to the left of the midline incisal line.
- Subjects who gave their written informed consent to take part of the study.
Exclusion Criteria:
- Patient with cardiac pacemaker
- Patients suffering from psychological, neurological or psychiatric disorders
- Pregnant or breastfeeding women
- Cancer patients undergoing therapy
- Patients taking bisphosphonates within the last 12 months
- Patients with low compliance or inconsistent motivation
- Drug or alcohol users
- Presence of periodontal probes exclusively on the right or left side compared to the midline incisal line
Sites / Locations
- Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Biorepair Gel (Q1-Q3) and Chlorhexidine 1% gel (Q2-Q4)
Chlorhexidine 1% gel (Q1-Q3) and Biorepair Gel (Q2-Q4)
The patients receive Biorepair Gel application in quadrants Q1 and Q3, whereas they receive chlorhexidine 1% gel in quadrants Q2 and Q4.
The patients receive chlorhexidine 1% gel in quadrants Q1 and Q3, whereas they receive Biorepair Gel application in quadrants Q2 and Q4.